Table 2 Prevalence of polypharmacy in the studied population according to the variables: gender, age, drug interactions, potentially inappropriate medications for patients and therapeutic duplicity
Variable | Prevalence (%) | PR(a) | CI 95% | p-value |
|---|---|---|---|---|
Gender | ||||
Man | 38.10 | 1.00 | ||
Woman | 31.33 | 0.82 | (0.5–1.36) | 0.28 |
Age | ||||
≥ 80 | 31.58 | 0.86 | (0.52–1.41) | 0.34 |
< 80 | 36.73 | 1.00 | ||
Potential drug interactions | ||||
Yes | 92.86 | 2.14 | (1.65–2.78) | <0.0001 |
No | 43.37 | 1.00 | ||
Potentially inappropriate medications for the elderly | ||||
Yes | 97.62 | 1.53 | (1.29–1.81) | <0.0001 |
No | 63.86 | 1.00 | ||
Therapeutic duplicity | ||||
Yes | 57.14 | 5.27 | (2.7–10.3) | <0.0001 |
No | 10.84 | 1.00 | ||